PARP Inhibitors for Ovarian Cancer

from Cancer Network Podcasts · host Cancer Network

We interview two prominent ovarian cancer researchers from both sides of the Atlantic, Dr. Michael Birrer and Dr. Jonathan Ledermann, on the role of PARP inhibitors and the challenges of developing ovarian cancer therapies.

Episode metadata supplied by the publisher feed · Published Mar 7, 2012

Embed this episode

Attribution link and audio player

NOW PLAYING

PARP Inhibitors for Ovarian Cancer

0:00 15:03

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Cancer Network Podcasts?

This episode is 15 minutes long.

When was this Cancer Network Podcasts episode published?

This episode was published on March 7, 2012.

Can I download this Cancer Network Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!